Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Disease area: Airway diseases

Abstract

Background: A newly-discovered type 2 innate lymphoid cell (ILC2), which acted as an early source of Th2 cytokines such as IL-5/IL-13 has been found involved in the pathogenesis of asthma. In this study, we will investigate the correlation between pathological ILC2s and asthma clinical characteristics . Methods: A total of 42 persistent asthma and 26 healthy subjects were enrolled in this study. Frequency of IL-13⁺ILC2 in the groups of asthmatics and healthy donors were checked by FACS . Sorted ILC2s were stimulated with IL-25 plus IL-33 in different time points, cytokine profiles were checked by multiplex ELISA; Correlation between IL-13⁺ILC2 and varied clinical data were analyzed. Measurements and Main Results: Human ILC2s were identified successfully as Lin^-CD45^highIL-7R⁺CRTH2⁺ cells, the percentages of ILC2s were 0.022±0.016% in asthmatics and 0.016±0.007% in healthy donors respectively. Percentages of IL-13⁺ILC2 were significantly higher in PBMCs of poorly-controlled group (53.1±16.3%) or part-control group (37.9+11.7) than well-controlled group (17.9±6.33%) and healthy controls group (18.2±9.4%) (p<0.05). Sorted ILC2s showed high IL-5- and IL-13-producing capabilities in response to IL-25+IL-33. Pathological ILC2 (IL-13⁺ILC2) was positively correlated with asthma control systems (R²=0.56, 0.62 respectively; p<0.05). Conclusions: ILC2 not PBMC, produce huge amount of Th2-like cytokines (IL-5, IL-13) which have been proved to involve in the pathogenesis of asthma. The frequency of pathological ILC2 (IL-13⁺ILC2) was positively correlated with the control status of asthma which has the potential to be an objective indicator for assessing asthma control in the future.


Rating:

Share or cite this content

Citations should be made in the following way:
Zhihong Chen (Shanghai, China), Zhihong Chen, Yi Jia, Renhong Tang, Chunxue Bai. Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics. Eur Respir J 2016; 48: Suppl. 60, 561

Member's Comments

No comment yet.

Related content which might interest you: Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Clinical characteristics, airway inflammation, and adipocytokines in overweight and obese asthmatics Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Epoxy and delayed asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Overlap phenotypes of asthma in adults: Obesity and atopy Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Early- and late-onsets of severe asthma are associated with divergent phenotypes of the disease Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Asthma clusters in a real asthmatic population, treated in secondary medical care Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Asthma and the role of blood glucose monitoring Source: International Congress 2016 – Systemic biomarkers Year: 2016 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Study of the small airway and its role in pediatric asthma control assessment Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 What is important to people with asthma: Maximising research impact? Source: International Congress 2015 – Any news from the asthma field? Year: 2015